Danaher (DHR) Stock Price, Quote, News & History | Benzinga

Danaher (DHR) Stock Price, Quote, News & History

DHRNYSE

Logo brought to you by Benzinga Data

Trade with Public

Trade with Public

$215.75

-3.78-1.72%

At close: Feb 5, 4:00 PM EST

$216.19

0.440.20%

After Hours: 4:28 PM EST

Overview

News Earnings Options Guidance Dividends Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$219.08

Close

$215.75

Volume / Avg.

4.10M / 3.63M

Day Range

$214.94 - $220.00

52 Wk Range

171.00 - 242.80

Market Cap

$152.82B

P/E Ratio

43.64

Dividend Yield

0.58%

Exchange

NYSE

RSI

36

Short Interest

1.32%

Days to Cover

3.19

Recent Danaher Corp News

Revvity Sees Steady Growth On Rising Demand From Pharma/Biotech Customers

Revvity beat Q4 earnings and revenue estimates, driven by diagnostics growth, and forecast higher 2026 profit and sales as end markets show signs of improvement.

Vandana Singh

Gold Rallies To $5,300, Memory Stocks Go Wild: What's Moving Markets Wednesday?

Wall Street posted modest gains on Wednesday, while gold extended its relentless rally, shattering records above $5,300 an ounce ahead of the Federal Open Market Committee meeting.

Piero Cingari

Danaher Expects Gradual Improvement In End-Market Conditions

Danaher beat Q4 sales and earnings estimates, showed strength in bioprocessing and diagnostics, and issued a steady 2026 outlook, even as shares traded lower in premarket action.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

6.32B

Investing Cash Flow (TTM)

-1.51B

Financing Cash Flow (TTM)

-5.98B

Free Cash Flow (TTM)

5.02B

Capital Expenditure (TTM)

-1.30B

Net Change in Cash (TTM)

-1.16B

Analyst Trends and Forecast

1

Sep 25

3

2

Oct 25

2

1

Dec 25

4

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$168.99B

PE Ratio (TTM)

43.64

PE Ratio (FWD)

25.97

PEG Ratio (TTM)

2.06

PS Ratio (TTM)

6.40

PB Ratio (TTM)

2.95

Earnings Yield % (TTM)

2.29%

Earnings Yield % (FWD)

3.85%

EV / EBITDA (TTM)

24.33

Price / EBITDA (TTM)

22.64

Price / Free Cash Flow (TTM)

29.89

Book Value / Share

$74.32

Company Debt

Total Debt

$16.86B

LT Debt

$16.83B

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$1.20B

Total Cash

$1.53B

Debt to Equity

0.35

Issuance of Debt (TTM)

-$1.20B

Repayment of Debt (TTM)

-$1.20B

Key Statistics

Open

$219.08

Close

$215.75

Volume / Avg.

4.10M / 3.63M

Day Range

$214.94 - $220.00

52 Wk Range

171.00 - 242.80

Market Cap

$152.82B

P/E Ratio

43.64

Dividend Yield

0.58%

Exchange

NYSE

RSI

36

Short Interest

1.32%

Days to Cover

3.19

About

Sector

Health Care

Industry

Life Sciences Tools & Services

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instrume...

Show More

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Danaher (DHR) stock?

A

You can purchase shares of Danaher (NYSE:DHR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Danaher (DHR) competitors?

A

Other companies in Danaher’s space includes: Medpace Holdings Inc (NASDAQ:MEDP), Agilent Technologies Inc (NYSE:A), Icon PLC (NASDAQ:ICLR), 10x Genomics Inc (NASDAQ:TXG) and Waters Corp (NYSE:WAT).

Q

What is the forecast, or price target, for Danaher (DHR) stock?

A

Danaher has a consensus price target of $261.04.

Q

What is the current price for Danaher (DHR)?

A

The stock price for Danaher (NYSE: DHR) is $216.19 last updated February 5, 2026 at 4:28 PM EST.

Q

Does Danaher (DHR) pay a dividend?

A

There are no upcoming dividends for Danaher.

Q

When is Danaher (NYSE:DHR) reporting earnings?

A

Danaher does not have any upcoming earnings scheduled.

Q

Is Danaher (DHR) going to split?

A

There is no upcoming split for Danaher.

Q

What sector and industry does Danaher (DHR) operate in?

A

Danaher is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.

People Also Watch

Medpace Holdings Inc

Agilent Technologies Inc

10x Genomics Inc

Sotera Health Co

Fortrea Holdings Inc